Some of the medtech's biggest players may take a serious hit in China, a long-sought emerging market, where regulators are pushing for greater use of homegrown technologies to stem skyrocketing healthcare costs.
MASSDEVICE ON CALL — Chinese regulators are pushing local healthcare systems to look within when buying new medical products, a campaign that could spell bad news for global medtech giants that have placed big bets on the country's emerging healthcare market.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rXtomB
Cap comentari:
Publica un comentari a l'entrada